NICE nod for Genedrive’s CYP2C19 candidate
Screening patients to assess their clopidogrel resistance status will allow for alternative treatments
Read More
Tag: CYP2C19
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
